HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spanish OTC Industry Round-Up: Esteve Buys Riemser, Cinfa Invests, ANEFP Trains Pharmacists

Executive Summary

Esteve acquires Germany’s Riemser, Cinfa invests €200m over four years, and Spanish self-care association, ANEFP, restarts its successful pharmacy training program.

You may also be interested in...



Towa Expands Internationally With Esteve’s Pensa

Japan’s Towa has struck a deal to acquire the Pensa Investments generics division of Spain’s Esteve in an all-cash transaction worth €320m. The acquisition gives Towa access to the Spanish market as well as subsidiaries in Europe and the US.

Vemedia Acquires GSK Brands In Italy, Strikes Deal For GI Product In Spain

GSK has offloaded a further two brands, this time in Italy, giving Netherlands-based Vemedia the opportunity to bolster its portfolio in the country. Vemedia has also added to its offering in Spain by striking a separate deal with Puerto Galiano.

Spain's Kern Pharma Combats Dry Mouth With Salifresh Launch

Spanish consumers suffering from dry mouth have a new option to turn to with the launch of Kern Pharma's Salifresh.

Related Content

Topics

UsernamePublicRestriction

Register

RS149602

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel